Advancing science or advancing careers? Researchers' opinions on success indicators.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 29 06 2020
accepted: 24 11 2020
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 2 7 2021
Statut: epublish

Résumé

The way in which we assess researchers has been under the radar in the past few years. Critics argue that current research assessments focus on productivity and that they increase unhealthy pressures on scientists. Yet, the precise ways in which assessments should change is still open for debate. We circulated a survey with Flemish researchers to understand how they work, and how they would rate the relevance of specific indicators used in research assessments. We found that most researchers worked far beyond their expected working schedule. We also found that, although they spent most of their time doing research, respondents wished they could dedicate more time to it and spend less time writing grants and performing other activities such as administrative duties and meetings. When looking at success indicators, we found that indicators related to openness, transparency, quality, and innovation were perceived as highly important in advancing science, but as relatively overlooked in career advancement. Conversely, indicators which denoted of prestige and competition were generally rated as important to career advancement, but irrelevant or even detrimental in advancing science. Open comments from respondents further revealed that, although indicators which indicate openness, transparency, and quality (e.g., publishing open access, publishing negative findings, sharing data, etc.) should ultimately be valued more in research assessments, the resources and support currently in place were insufficient to allow researchers to endorse such practices. In other words, current research assessments are inadequate and ignore practices which are essential in contributing to the advancement of science. Yet, before we change the way in which researchers are being assessed, supporting infrastructures must be put in place to ensure that researchers are able to commit to the activities that may benefit the advancement of science.

Identifiants

pubmed: 33571992
doi: 10.1371/journal.pone.0243664
pii: PONE-D-20-19974
pmc: PMC7878066
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243664

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nature. 2016 Oct 26;538(7626):444
pubmed: 27786225
PLoS Biol. 2020 Jul 16;18(7):e3000737
pubmed: 32673304
Nature. 2019 Nov;575(7782):257-258
pubmed: 31723298
J Occup Health. 2016 Jul 22;58(4):340-6
pubmed: 27265530
Nature. 2015 Apr 23;520(7548):429-31
pubmed: 25903611
PLoS Biol. 2018 Mar 29;16(3):e2004089
pubmed: 29596415
Nature. 2016 Oct 26;538(7626):446-449
pubmed: 27786221
BMJ Open. 2016 Feb 17;6(2):e008681
pubmed: 26888726
Nature. 2018 Jun;558(7710):345
pubmed: 29921857
BMJ Open. 2013 May 28;3(5):
pubmed: 23793700
J Grad Med Educ. 2013 Dec;5(4):541-2
pubmed: 24454995
BMJ. 2019 Dec 19;367:l6460
pubmed: 31857333
Res Integr Peer Rev. 2021 Jan 14;6(1):3
pubmed: 33441167
J Med Libr Assoc. 2003 Jan;91(1):42-6
pubmed: 12572533
EMBO Rep. 2011 Jul 08;12(8):758-62
pubmed: 21738219
Nat Biotechnol. 2018 Mar 6;36(3):282-284
pubmed: 29509732
Res Integr Peer Rev. 2021 Jan 14;6(1):1
pubmed: 33441187
Stress Health. 2016 Dec;32(5):551-558
pubmed: 26620490
Nature. 2013 Aug 1;500(7460):29
pubmed: 23903742

Auteurs

Noémie Aubert Bonn (N)

Healthcare and Ethics Research Group, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

Wim Pinxten (W)

Healthcare and Ethics Research Group, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH